As we reach the end of another eventful year, the pharmaceutical startup ecosystem in India depicts its essence through resilience, innovation and growth. 2024 has been a remarkable year for the sector, characterized by historic milestones, rising investments, and a fast growing footprint in healthcare. Indian pharma startups went to great lengths during the year in research and development. These innovators did not stop at producing generic affordable medicines, but had a more complex focus on biosimilars and biologics, which are also available at lower costs than what normal medicines... >>More
Dheeraj Jain, Founder, Redcliffe Labs
Dr. Poovamma CU, Senior Consultant & Director - Breast Oncology, Cytecare Hospitals
Saji Mathew, Chief Operating Officer, Baby Memorial Hospital
Dr. Veena Panicker, Director - BioMonitoring, Merck Life Science
Vaibhav Tewari, Co-Founder & CEO, Portea
Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre